₹ 9.22
NAV (May 02)
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Expense Ratio | 0.61 % |
Launched <1Y | 2024-12-27 |
AUM in Crores | 307.4 |
ISIN | INF0QA701AB9 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | - |
Standard Deviation | - |
Beta | - |
Sharpe Ratio | - |
YTM | - |
Healthcare
82.92%Consumer Staples
7.47%Services
0.89%Materials
0.53%Chemicals
0.44%Fund Name | Fund Size | |
---|---|---|
₹ 49,131 cr | ||
₹ 93,440 cr | ||
₹ 64,962 cr | ||
₹ 23,379 cr | ||
₹ 27,730 cr |